Arcutis Biotherapeutics I... (ARQT)
NASDAQ: ARQT
· Real-Time Price · USD
20.91
-0.72 (-3.33%)
At close: Oct 16, 2025, 3:59 PM
21.08
0.81%
After-hours: Oct 16, 2025, 07:57 PM EDT
-3.33% (1D)
| Bid | 19.89 |
| Market Cap | 2.51B |
| Revenue (ttm) | 263.46M |
| Net Income (ttm) | -93.27M |
| EPS (ttm) | -0.73 |
| PE Ratio (ttm) | -28.64 |
| Forward PE | 136.2 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 21.69 |
| Volume | 1,580,527 |
| Avg. Volume (20D) | 2,054,039.9 |
| Open | 21.75 |
| Previous Close | 21.63 |
| Day's Range | 20.35 - 21.84 |
| 52-Week Range | 8.03 - 21.84 |
| Beta | 2.06 |
| Ex-Dividend Date | n/a |
About ARQT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARQT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARQT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsArcutis Biotherapeutics Inc. is scheduled to release its earnings on
Oct 28, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+12.31%
Arcutis Biotherapeutics shares are trading higher ...
Unlock content with
Pro Subscription
7 months ago
+8.36%
Arcutis Biotherapeutics shares are trading higher after the company reported better-than-expected Q4 financial results.
